On or around 09/26/2017 (Stipulation and order of dismissal (voluntary dismissal))
Filing Date: June 02, 2017
According to the Complaint, on April 23, 2017, Bard’s Board of Directors (the “Board” or “Individual Defendants”) caused the Company to enter into an agreement and plan of merger (the “Merger Agreement”) with BD. Pursuant to the terms of the Merger Agreement, shareholders of Bard will receive $222.93 in cash and 0.5077 shares of BD stock for each share of Bard common stock.
On May 23, 2017, defendants filed a Form S-4 Registration Statement (the “Registration Statement”) with the United States Securities and Exchange Commission (“SEC”) in connection with the Proposed Transaction. The Complaint alleges the Registration Statement omits material information with respect to the Proposed Transaction, which renders the Registration Statement false and misleading.
Company & Securities Information
Defendant: C. R. Bard, Inc.
Industry: Medical Equipment & Supplies
Headquarters: United States
Ticker Symbol: BCR
Company Market: New York SE
Market Status: Public (Listed)
About the Company & Securities Data
"Company" information provides the industry and sector classification and headquarters state for the primary company-defendant in the litigation. In general, "Securities" information provides the ticker symbol, market, and market status for the underlying securities at issue in the litigation.
In most cases, the primary company-defendant actually issued the securities that are the subject of the litigation, and the securities information and company information relate to the same entity. In a small subset of cases, however, the primary company-defendant is not the issuer (for example, cases against third party brokers/dealers), and the securities information and company information do not relate to the same entity.
First Identified Complaint
Barbara Stanford Tanguma, et al. v. C. R. Bard, Inc., et al.